Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58))
Publication
, Journal Article
Lopes, RD; Al-Khatib, SM; Wallentin, L
Published in: The Lancet
January 1, 2013
Duke Scholars
Published In
The Lancet
EISSN
1474-547X
ISSN
0140-6736
Publication Date
January 1, 2013
Volume
381
Issue
9862
Start / End Page
204
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., Al-Khatib, S. M., & Wallentin, L. (2013). Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)). The Lancet, 381(9862), 204.
Lopes, R. D., S. M. Al-Khatib, and L. Wallentin. “Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)).” The Lancet 381, no. 9862 (January 1, 2013): 204.
Lopes RD, Al-Khatib SM, Wallentin L. Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)). The Lancet. 2013 Jan 1;381(9862):204.
Lopes, R. D., et al. “Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)).” The Lancet, vol. 381, no. 9862, Jan. 2013, p. 204.
Lopes RD, Al-Khatib SM, Wallentin L. Erratum: Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fi brillation: A secondary analysis of a randomised controlled trial (The Lancet (2012) 380 (1749-58)). The Lancet. 2013 Jan 1;381(9862):204.
Published In
The Lancet
EISSN
1474-547X
ISSN
0140-6736
Publication Date
January 1, 2013
Volume
381
Issue
9862
Start / End Page
204
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences